refractory epilepsy
Post on 15-Dec-2014
83 Views
Preview:
DESCRIPTION
TRANSCRIPT
Refractory epilepsy management stategies
Dr Parag Moon Senior Resident
Dept of NeurologyGMC Kota
Definition In investigational studies, criteria of
refractoriness include: (1) absence of response to 2 AEDs tolerated at
reasonable doses; (2) minimum frequency of seizures (e.g. 1
seizure per month) to be considered refractory or the duration of minimum remission (e.g. 6– 12 months) to be qualified as nonrefractory,
(3) duration of 1 year to 1 decade of noncontrolled epilepsy
Flexible scale of refractoriness potential (no seizure freedom with AEDs
taken less than 1 year and predictive factors for refractoriness)
probable (no seizure freedom more than 1 year with at least 2 AEDs)
definitely refractory(catastrophic epilepsy or no freedom of seizure for more than 1 year after 5 years of treatment with at least 3 AEDs)
Predictive Factors of Refractoriness1. Epileptic syndromeOnly 13% with idiopathic generalized epilepsy,
and no case with idiopathic partial epilepsy, were refractory.
Typical refractory generalized epilepsy of pediatric ages are the Ohtahara syndrome, early myoclonic encephalopathy (neonatal period), West syndrome, Dravet syndrome (infancy) and Lennox-Gastaut syndrome (early childhood) .
In focal epilepsy, hippocampal sclerosis, cortical dysplasia and hemorrhage are associated with refractoriness .
2. Localization of the epileptogenic zoneThe temporal lobe ,striate cortex, namely the
fourth layer .3.Response to AEDs-Absence of seizure
freedom when 2 past AEDs proved inefficient4.Younger Age of onset5.Seizure frequency at epilepsy onset
6. Electroencephalography -Quantity of interictal spikes is predictive of severity in temporal lobe epilepsy
Oligospikers-less than 1 spike per hour less severe epilepsy
Association between multifocal spikes and intractability
Frequency of refractory epilepsy varies from 10 to 37.5%
Diagnosis of Refractory EpilepsyExclude false refractoriness related to
nonepileptic seizures, inadequate AEDs, noncompliance and seizure-precipitating factors
Defined as inadequate control of seizures despite at least 2 potentially effective AEDs (mono- or polytherapy) taken in tolerable doses
Treatment of Refractory EpilepsyNon pharmacologicClassic ketogenic diet -high fat content and
low carbohydrate ContentThe medium chain triglyceride (MCT) diet Modified Atkins diet (MAD)Low glycemic index treatment (LGIT).
Classic ketogenic diet is a high fat and low carbohydrate diet that uses long chain fatty acids (LCFAs) as its main source of fat.
Patient must consume 3–4 grams of fat for every 1 gram of carbohydrate plus protein
In MCT more carbohydrates and proteins can be consumed for every gram of fat and is more ketogenic
No limit on the amount of protein consumed or the total number of calories per day in MAD
Typical MAD uses a ratio of 1 gram of fat for every gram of carbohydrate plus protein, is less restrictive than the other two high fat diets.
LGIT restricts carbohydrate intake to food items with a glycemic index of less than 50 at 40–60 grams per day, in order to prevent large fluctuations in blood glucose concentrations, which are thought to exacerbate seizures.
15.6%–15.8% of patients on the diet can achieve seizure freedom whilst 33.0%–55.8% of the patients can have a >50% reduction in number of seizures
West syndrome (infantile spasms)-ketogenic diet is used as a first line agent.
Also recommended for patients suffering from glucose transporter defects and pyruvate dehydrogenase deficiency,
Effects of a ketogenic diet can be seen within a few days and is cost effective
Side effects of dietary treatments are constipation, acidosis, temporary hypercholesterolemia, kidney stones and hunger, Growth restriction
Contraindicated in pyruvate decarboxylase deficiency, primary carnitine deficiency, fatty acid oxidation abnormalities, the porphyrias and some mitochondrial disorders
Herbal medicine Cannabinoids have the largest body of
evidence supporting their use as anticonvulsant.
Approved in canada and licensed in 14 states of America
Other -kava (Piper methysticum) and mistletoe (Viscum sp)
Surgical management Candidates for Epilepsy SurgeryIdeally have a single epileptogenic focus in a
non-eloquent cortical regionIntractable epilepsyPresent for a substantial duration (usually
years)Refractory to medical therapySubstantially impairing quality of lifeBenefit of surgery should outweigh the risks
Evaluation of Candidates for Epilepsy Surgery
Localization of seizures by interictal EEGLocalization by brain imaging-MRI; PET
scanningLocalization by video-EEG monitoring of
seizures ( may combine with ictal SPECT)Localization by neuropsychological testingOther methods-Depth electrodes,Cortical
grids or strips,Nuclear magnetic resonance scans,Magnetoencephalography
Types of Resective Epilepsy Surgery
Temporal lobectomyExtratemporal resections (lobar: frontal,
occipital)Corpus CallosotomyHemispherectomyMultiple subpial transections
68% of the patient who received temporal lobectomies experienced seizure remission for 2 years.
Side effects – period of disability, infection, transient endocrine abnormalities, transient dysphoria, depression,occasionally mania
Permanent neurological and neuropsychological complications
Possibility to create new lesions which may become epileptogenic
Vagus Nerve Stimulation (VNS)
Approved by FDA in July 1997Patients with intractable epilepsy ≥ 12 yo
• Intermittent electrical stimulation is delivered to the left vagus nerve, which has ascending fibers with widespread connections to the limbic, autonomic and reticular brain regions
Proposed Mechanisms of Action for VNS
Desynchronization of EEGSuppression of spikesBlock ictal rhythmic build-up in a seizureRelease of GABA and GlycineEffects on limbic and brainstem systemsIncreased thalamic blood flow
Benefits of Vagus Nerve Stimulation
Median seizure reduction of 24.5%–28.0% in the group receiving high level VNS compared to just 6.1%–15.0% in patients receiving low level VNS
Effect increases over timeSeizure severity decreasedImproved level of alertness (medication may be
decreased)Few adverse effects-Hoarseness, sleep
apnoea,infection (rare)Batteries require replacement every ~ 10 yrs
Deep brain stimulation DBS involves electrical stimulation of specific
subcortical nuclei, which have widespread neural connections.
Anterior nucleus of the thalamus is often the target of DBS.
Centromedian nucleus is also a potential location for DBS
Complications -Infection, hemorrhage and stimulation-induced seizures
Impaired memory and higher levels of depression
Responsive neurostimulation (RNS)
Does not deliver electrical stimulation throughout the day.
RNS device is composed of a combined recorder and stimulator device
Detects clinically relevant epileptiform discharges and delivers an appropriate electrical stimuli in response
Reduction in seizure frequency of 37.9% in the treatment arm compared to 17.3% in the control group
Other modalities available-repetitive transcranial magnetic stimulation (rTMS).
Based on principles of electromagnetic induction, where small intracranial electric currents are generated by a strong fluctuating extracranial magnetic field.
Risk of precipitating seizures
Thanks
References Pharmacotherapeutic and Non-Pharmacological Options
for Refractory and Difficult-to-Treat Seizures ;James W. Mitchell et al ; Journal of Central Nervous System Disease 2012:4 ;105–115
Refractory Epilepsy: A Clinically Oriented Review;Pedro Beleza; Eur Neurol 2009;62:65–71
Schuele SU, Luders HO: Intractable epilepsy: management and therapeutic alternatives. Lancet Neurol 2008; 7: 514–524
Treatment of refractory epilepsy: Barbara Oslon: Adv Stud Med 2005:5:470-473
top related